Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aemetis (AMTX)
NASDAQ:AMTX
Holding AMTX?
Track your performance easily
AMTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.10 - $7.03
Previous Close$3.59
Volume4.05M
Average Volume (3M)557.45K
Market Cap
$169.44M
Enterprise Value$478.22M
Total Cash (Recent Filing)$234.00K
Total Debt (Recent Filing)$309.02M
Price to Earnings (P/E)―
Beta3.74
Next Earnings
Mar 06, 2025EPS Estimate
-$0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.09
Shares Outstanding47,196,649
10 Day Avg. Volume1,029,957
30 Day Avg. Volume557,454
Standard Deviation0.44
R-Squared0.02
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)-0.88
Price to Sales (P/S)0.61
Price to Cash Flow (P/CF)-8.30
P/FCF Ratio61.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.90
Enterprise Value/Gross Profit237.09
Enterprise Value/Ebitda-8.53
Forecast
1Y Price Target
$19.00Price Target Upside311.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Aemetis News
PremiumCompany Announcements
Aemetis Inc. Reports Q3 2024 Financial Results
Ownership Overview
8.37% Insiders
8.51% Mutual Funds
0.55% Other Institutional Investors
75.04% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMTX FAQ
What was Aemetis’s price range in the past 12 months?
Aemetis lowest stock price was $2.10 and its highest was $7.03 in the past 12 months.
What is Aemetis’s market cap?
Currently, no data Available
When is Aemetis’s upcoming earnings report date?
Aemetis’s upcoming earnings report date is Mar 06, 2025 which is in 113 days.
How were Aemetis’s earnings last quarter?
Aemetis released its earnings results on Nov 12, 2024. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.383 by $0.003.
Is Aemetis overvalued?
According to Wall Street analysts Aemetis’s price is currently Undervalued.
Does Aemetis pay dividends?
Aemetis does not currently pay dividends.
What is Aemetis’s EPS estimate?
Aemetis’s EPS estimate is -$0.35.
How many shares outstanding does Aemetis have?
Aemetis has 47,196,648 shares outstanding.
What happened to Aemetis’s price movement after its last earnings report?
Aemetis reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.383. Following the earnings report the stock price went down -17.134%.
Which hedge fund is a major shareholder of Aemetis?
Among the largest hedge funds holding Aemetis’s share is GoalVest Advisory LLC. It holds Aemetis’s shares valued at 12K.
---
Aemetis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$19.00 (311.26% Upside)
$19.00 (311.26% Upside)
Blogger Sentiment
Bullish
AMTX Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 7.1%
Last 30 Days ▲ 7.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.57%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
9.17%
Trailing 12-Months
Company Description
Aemetis
Aemetis, Inc. operates as a renewable fuels and biochemicals company. The firm focuses on the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into biorefineries. It operates through the North America and India segments. The North America segment comprises of the Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, the Goodland Plant, and the research and development facility in Minnesota. The India segment includes the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2005 and is headquartered in Cupertino, CA.
---
AMTX Earnings Call
Q2 2024
0:00 / 0:00
---
AMTX Stock 12 Month Forecast
Average Price Target
$19.00
▲(311.26% Upside)
Technical Analysis
Best Analysts Covering AMTX
1 Year
1 Year Success Rate
5/15 ratings generated profit
1 Year Average Return
-18.08%
reiterated a buy rating 3 months ago
Copying Amit Dayal's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -18.08% per trade.
---